AbbVie is adding Humira to the TrumpRx discount program at $950, an 86% reduction from over $6,900 for uninsured patients123
Genentech joins with Xofluza at around $50, down from $16813
Amgen expands offerings to include Enbrel and Otezla13
TrumpRx now features over 61 drugs, up from 40 at launch in February 202613
New offerings launch as soon as Monday, April 8, 2026, for uninsured or uncovered patients13
AbbVie's deal includes tariff exemptions and R&D pledges in exchange for participation2
Sources:
1. https://nationaltoday.com/us/dc/washington/news/2026/04/06/abbvie-genentech-to-join-trumprx-discount-drug-program/
2. https://www.biospace.com/policy/abbvie-puts-humira-on-trumprx-at-steep-discount-as-tariff-threat-solidifies
3. https://www.cbsnews.com/news/trumprx-abbvie-genentech-prescription-drugs/